NAVELBINE

This brand name is authorized in Austria, Australia, Brazil, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Italy, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug NAVELBINE contains one active pharmaceutical ingredient (API):

1 Vinorelbine
UNII 253GQW851Q - VINORELBINE TARTRATE

Vinorelbine is an antineoplastic drug of the vinca alkaloid family but unlike all the other vinca alkaloids. Vinorelbine inhibits tubulin polymerization and blocks mitosis at G2-M, causing cell death in interphase or at the following mitosis.

Read about Vinorelbine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
L01CA04 Vinorelbine L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01C Plant alkaloids and other natural products → L01CA Vinca alkaloids and analogues
Discover more medicines within L01CA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 4620E, 7263G, 9009E, 9010F
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 507003601152310, 507003602159319, 507003603112316, 507003604119314
Country: EE Ravimiamet Identifier(s): 1039979, 1069602, 1456411, 1456422, 1595594, 1595606
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 59300, 65978, 65979
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 002943, 003164, 003175, 168997, 169433
Country: FR Base de données publique des médicaments Identifier(s): 61168991, 63413635, 64503288, 68184425
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 155170, 48043, 48044, 95226, 95229
Country: HK Department of Health Drug Office Identifier(s): 44009, 56212, 56213
Country: IE Health Products Regulatory Authority Identifier(s): 88431, 88492
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 6500, 6504
Country: IT Agenzia del Farmaco Identifier(s): 027865106, 027865118
Country: JP 医薬品医療機器総合機構 Identifier(s): 4240407A1028, 4240407A2024
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1004236, 1004237, 1065716, 1065717, 1067907, 1067908
Country: MT Medicines Authority Identifier(s): AA565/73701
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 625M2003
Country: NL Z-Index G-Standaard Identifier(s): 14645971, 14646005
Country: NL Z-Index G-Standaard, PRK Identifier(s): 118109, 118117, 58815, 58823
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 11625, 11626, 7690
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100046499, 100108817, 100108823
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W42512001, W42512002, W42513001, W42513002
Country: SG Health Sciences Authority Identifier(s): 06778P, 12546P, 12547P
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 6063121H, 6063124H, 6063125H, 6063126H
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699749190039, 8699749190046, 8699749770019, 8699749770026
Country: US FDA, National Drug Code Identifier(s): 64370-532
Country: ZA Health Products Regulatory Authority Identifier(s): 30/26/0123, 30/26/0124, 36/26/0012, 36/26/0013, 36/26/0014, 36/26/0015

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.